At the very beginning, the rationale for their use was quite simple: there was one symptom, anemia; there was a new effective drug to cure it, recombinant human erythropoietin; therefore, it was administered to increase Hb levels. This evidence concerns the gene GSTM1 and anemia (phenotype).